Additional information
Brown Powder; Hygroscopic
865792-18-3
ACI-037811
NA
C31H45N9O2
575.75
Ambient
2-8°C
Anti-stroke agent
Pharmaceutical Impurity Standards
1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one
1-(4-(5-Cyclohexyl-1H-tetrazol-1-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one
6-[4-(1-cyclohexyl-1H-1,2,3,4-tetrazol-5-yl)butoxy]-1-[4-(1-cyclohexyl-1H-1,2,3,4-tetrazol-5-yl)butyl]-1,2,3,4-tetrahydroquinolin-2-one





![N-METHYL REGADENOSON (25 mg) (1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N,N-dimethylpyrazole-4-carboxamide )](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)